07:00 , Jul 16, 2012 |  BC Week In Review  |  Company News

Anagnostics, Molzym deal

Molzym granted Anagnostics rights to use Molzym's SepsiTest sample preparation technology to develop the hybcell Pathogens DNA system for identifying sepsis-causing pathogens in whole blood samples in less than four hours. Anagnostics will combine SepsiTest...
08:00 , Nov 7, 2011 |  BC Week In Review  |  Company News

Anagnostics, Diatech deal

Anagnostics partnered with Diatech to develop new and existing companion diagnostic tests in oncology. The deal includes Anagnostics' hybcell Oncogenes Tissue plex A test, which is designed to detect mutations in the K-Ras gene that...
08:00 , Nov 7, 2011 |  BC Week In Review  |  Company News

Anagnostics, Cell.Eng. sales and marketing update

Anagnostics granted Cell.Eng. rights to market hybcell Oncogenes Tissue plex A test in Italy. The test is designed to detect mutations in the K-Ras gene that circumvent EGFR inhibitor therapies. Anagnostics hopes to launch the...